[HTML][HTML] Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
…, GA Gaich, JY Reginster, AB Hodsman… - New England journal …, 2001 - Mass Medical Soc
Background Once-daily injections of parathyroid hormone or its amino-terminal fragments
increase bone formation and bone mass without causing hypercalcemia, but their effects on …
increase bone formation and bone mass without causing hypercalcemia, but their effects on …
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use
AB Hodsman, DC Bauer, DW Dempster… - Endocrine …, 2005 - academic.oup.com
… *Address all correspondence and requests for reprints to: Anthony B. Hodsman, Professor
of Medicine, University of Western Ontario, \#8453; St. Joseph’s Health Care, Room 2F-15, …
of Medicine, University of Western Ontario, \#8453; St. Joseph’s Health Care, Room 2F-15, …
A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1–34)] with alendronate in postmenopausal women …
…, DC Cumming, AB Hodsman - The Journal of …, 2002 - academic.oup.com
Teriparatide (rDNA origin) injection [recombinant human PTH (1–34)] stimulates bone formation,
increases bone mineral density (BMD), and restores bone architecture and integrity. In …
increases bone mineral density (BMD), and restores bone architecture and integrity. In …
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate
…, MP Ettinger, DA Hanley, AB Hodsman… - The Journal of …, 2000 - academic.oup.com
Treatment of osteoporosis with PTH causes a marked increase in vertebral bone mineral
density (BMD). However, this effect is rapidly reversed when the treatment is stopped. The …
density (BMD). However, this effect is rapidly reversed when the treatment is stopped. The …
[HTML][HTML] The three-year incidence of fracture in chronic kidney disease
…, SM Cadarette, JG Pouget, CE Lok, AB Hodsman… - Kidney international, 2014 - Elsevier
Knowing a person’s fracture risk according to their kidney function, gender, and age may
influence clinical management and decision-making. Using healthcare databases from Ontario, …
influence clinical management and decision-making. Using healthcare databases from Ontario, …
Effects of a one‐month treatment with PTH (1–34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
…, J Nieves, DW Dempster, AB Hodsman - Journal of Bone and …, 2007 - academic.oup.com
Using bone histomorphometry, we found that a 1‐month treatment with PTH(1–34) [hPTH(1–34)]
stimulated new bone formation on cancellous, endocortical, and periosteal bone …
stimulated new bone formation on cancellous, endocortical, and periosteal bone …
Efficacy and safety of human parathyroid hormone-(1–84) in increasing bone mineral density in postmenopausal osteoporosis
AB Hodsman, DA Hanley, MP Ettinger… - The Journal of …, 2003 - academic.oup.com
Daily sc injections of N-terminal analogs of PTH increase bone mass and decrease fractures
in osteoporotic women. We investigated the efficacy and safety of human PTH-(1–84) (full-…
in osteoporotic women. We investigated the efficacy and safety of human PTH-(1–84) (full-…
Bone strength: the whole is greater than the sum of its parts
…, DA Hanley, D Goltzman, AB Hodsman… - Seminars in arthritis and …, 2006 - Elsevier
OBJECTIVE: To summarize the current knowledge regarding the various determinants of
bone strength. METHODS: Relevant English-language articles acquired from Medline from …
bone strength. METHODS: Relevant English-language articles acquired from Medline from …
Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment
…, SR Cummings, DA Hanley, SP Harris, AB Hodsman… - Clinical …, 2004 - Elsevier
Background: Osteoporosis and fragility fractures in men account for substantial health care
expenditures and decreased quality of life. Objective: This article reviews the most current …
expenditures and decreased quality of life. Objective: This article reviews the most current …
A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid Hormone Versus Cyclical Parathyroid Hormone and Sequential Calcitonin to Improve …
AB Hodsman, LJ Fraher, PH Watson… - The Journal of …, 1997 - academic.oup.com
Short cycles of human (h) PTH-(1–34) may have an anabolic effect to increase bone mass
in patients with osteoporosis. As PTH also stimulates bone resorption, it is theoretically …
in patients with osteoporosis. As PTH also stimulates bone resorption, it is theoretically …